EDIT - Editas Medicine, Inc.
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$5.00
DETAILS
HIGH:
$6.00
LOW:
$4.00
MEDIAN:
$5.00
CONSENSUS:
$5.00
UPSIDE:
81.16%
Profitability Ratios
| Ratio | Value |
|---|---|
| GP Margin | 100.0% |
| EBIT Margin | -379.8% |
| EBITDA Margin | -366.8% |
| Operating Margin | -245.2% |
| Pretax Margin | -395.0% |
| Cont. Ops Margin | -395.0% |
| Net Margin | -395.0% |
| Bottom Line Margin | -395.0% |
Liquidity Ratios
| Ratio | Value |
|---|---|
| Current Ratio | 3.54 |
| Quick Ratio | 3.54 |
| Solvency Ratio | -0.972 |
| Cash Ratio | 3.17 |
Valuation Ratios
| Ratio | Value |
|---|---|
| Price/Earnings |
-1.14
Peers avg: 25.8
|
| PEG Ratio | 0.03 |
| Forward PEG | 0.03 |
| Price/Book | 6.67 |
| Price/Sales | 4.49 |
| Price/FCF | -1.10 |
| Price/Op Cash Flow | -1.10 |
Debt Ratios
| Ratio | Value |
|---|---|
| Debt/Assets | 0.4112 |
| Debt/Equity | 2.8110 |
| Debt/Capital | 0.7376 |
| Long-Term Debt/Capital | 0.6627 |
| Financial Leverage | 6.84 |
Cash Flow Ratios
| Ratio | Value |
|---|---|
| Working Capital Turnover | 0.25 |
| Operating Cash Flow Ratio | -3.573 |
| Operating Cash Flow/Sales | -407.8% |
| Free Cash Flow/Operating Cash Flow | 100.4% |
Coverage Ratios
| Ratio | Value |
|---|---|
| Debt Service Coverage | -8.64 |
| Interest Coverage | -16.0972 |
| Short-Term Operating Cash Flow Coverage | -14.98 |
| Operating Cash Flow Coverage | -2.15 |
| Capital Expenditure Coverage | -272.23 |
| Dividend + Capital Expenditure Coverage | -272.23 |
Dividend Ratios
| Ratio | Value |
|---|---|
| Payout Ratio | 0.0000% |
| Dividend Yield | 0.0000% |
| Dividend Yield % | 0.0000% |
| Dividend Per Share | 0.0000 |
Per Share Ratios
| Ratio | Value |
|---|---|
| Revenue/Share | 0.46 |
| EPS | -1.804 |
| Debt/Share | 0.9339 |
| Cash/Share | 1.65 |
| Book Value/Share | 0.31 |
| Tangible BV/Share | 0.31 |
| Equity/Share | 0.31 |
| Operating Cash Flow/Share | -1.862 |
| Capital Expenditure/Share | 0.007 |
| FCF/Share | -1.869 |
Other Ratios
| Ratio | Value |
|---|---|
| Net Income/Earnings Before Tax | 1.000 |
| Earnings Before Tax/EBIT | 1.611 |
| Price/Fair Value | 6.67 |
| Debt/Market Cap | 0.3553 |
| Effective Tax Rate | 0.0% |
| Enterprise Value Multiple | -0.75 |